AbbVie (ABBV) Return on Equity [ROE] (2013 - 2025)
AbbVie (ABBV) reported Return on Equity [ROE] of 9006.38% for FY2025, up 8944.09 percentage points from 62.29% in FY2024.
Powered by 
Analysis
AbbVie (ABBV) Return on Equity [ROE] (2013 - 2025) Analysis & Trends
Dating back to FY2013, AbbVie's Return on Equity [ROE] record includes 11 years.
- Return on Equity [ROE] has a five-year change of +8818.69 percentage points (FY2020 to FY2025).
- The FY2025 figure ranks as the highest annual Return on Equity [ROE] in data going back to FY2013.
- According to Business Quant data, Return on Equity [ROE] came in at 62.29% in FY2024 (+27.09 pp), 35.20% in FY2023 (-37.19 pp), 72.40% in FY2022 (-8.56 pp) and 80.95% in FY2021 (-106.74 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 22.24% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 569.64% |
| Mar 31, 2025 | 174.18% |
| Dec 31, 2024 | 90.85% |
| Sep 30, 2024 | 79.63% |
| Jun 30, 2024 | 71.97% |
| Mar 31, 2024 | 65.11% |
| Dec 31, 2023 | 43.27% |
| Sep 30, 2023 | 52.11% |
| Jun 30, 2023 | 66.35% |
| Mar 31, 2023 | 49.64% |
| Dec 31, 2022 | 71.11% |
| Sep 30, 2022 | 87.37% |
| Jun 30, 2022 | 81.58% |
| Mar 31, 2022 | 78.66% |
| Dec 31, 2021 | 79.61% |
| Sep 30, 2021 | 57.64% |
| Jun 30, 2021 | 50.71% |
| Mar 31, 2021 | 38.52% |
| Dec 31, 2020 | 32.57% |
| Sep 30, 2020 | 49.20% |
API Access
AbbVie Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();